Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of January 5, 2025 • 8:00 PM ET

Date/Time Source News Release
12/30/2024 07:00 AM EST GlobeNewswire Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
12/09/2024 04:01 PM EST GlobeNewswire Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End
12/06/2024 04:01 PM EST GlobeNewswire Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
11/11/2024 07:00 AM EST GlobeNewswire Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting
11/07/2024 07:00 AM EST GlobeNewswire Chimerix Reports Third Quarter 2024 Financial Results and Provides Operational Update
11/01/2024 07:00 AM EDT GlobeNewswire Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024
10/18/2024 04:31 PM EDT GlobeNewswire Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09/03/2024 07:00 AM EDT GlobeNewswire Chimerix to Present at H.C. Wainwright 26th Annual Global Investment Conference
08/30/2024 04:05 PM EDT GlobeNewswire Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08/13/2024 07:00 AM EDT GlobeNewswire Chimerix Reports Second Quarter 2024 Financial Results and Provides Operational Update
Page

Additional News

As of January 5, 2025 • 8:00 PM ET

Date/Time Source News Release
12/30/2024 11:07 AM EST InvestorBrandNetwork Chimerix Inc. (NASDAQ: CMRX) Climbs to New 52-Week High
12/28/2024 09:00 AM EST SeekingAlpha Top-rated smaller defensive stocks after Societe Generale permabear takes contrarian view
12/11/2024 02:19 PM EST SeekingAlpha Chimerix: Big News, Big Moves, So Maybe Now's The Time To Buy
12/10/2024 09:54 AM EST 24/7 Market News Banzai Charging
12/10/2024 09:51 AM EST InvestorBrandNetwork Chimerix Inc. (NASDAQ: CMRX) Records 52-Week High Tuesday Morning
12/10/2024 08:28 AM EST SeekingAlpha Chimerix soars on seeking accelerated approval for its glioma treatment to U.S. FDA
12/10/2024 08:03 AM EST 24/7 Market News Chimerix Submitting NDA for Dordaviprone to FDA This Month, Seeking Accelerated Approval for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma
11/23/2024 02:48 PM EST SeekingAlpha WHO extends mpox emergency; Canada reports first Clade I case
11/17/2024 01:50 AM EST SeekingAlpha First mpox case linked to African outbreak reported in U.S.
11/10/2024 04:38 AM EST US Earnings Reports Expected earnings - Chimerix Inc.
Page